ORBERA™ Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

284

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
ObesityOverweight
Trial Locations (11)

21224

Johns Hopkins Bayview Medical Center, Baltimore

33716

Sun Coast Bariactrics, St. Petersburg

40215

Louisville Surgical Associates, Louisville

45241

Center for Metabolic and Bariatric Surgery, Cincinnati

48043

Allure Medical Spa, Mount Clemens

70001

Surgical Specialists of Louisiana, Metairie

70809

Digestive Health Center / Gastroroenterology Associates, Baton Rouge

72212

Applied Research Center of Arkansas, Inc, Little Rock

73069

Dr. Keith's Wellness Options, Norman

92120

Ellner Bariatric, San Diego

Unknown

Metroeast Endoscopic Surgery Center, Fairview Heights

Sponsors
All Listed Sponsors
lead

Apollo Endosurgery, Inc.

INDUSTRY

NCT02828657 - ORBERA™ Post-Approval Study | Biotech Hunter | Biotech Hunter